Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after ...

The sale of a French drugmaker to an American group is likely to now go ahead after French Economy Minister Antoine Armand ...

The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...

PARIS (Reuters) -The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane ...

Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's ...

Sanofi (EPA:SASY)(NASDAQ:SNY) has entered into exclusive negotiations with private equity firm Clayton, Dubilier&Rice to sell ...

Sanofi entered a fresh round of exclusive negotiations to sell control of its consumer health unit to Clayton Dubilier & Rice ...

Politicians and groups from all sides have said the sale of the popular Doliprane drug would be a 'loss of sovereignty'.

Unions in France are planning a walkout over the planned sale of the pharmaceutical company that makes popular painkiller ...

Doliprane, a brand name for paracetomol, is France's most popular medicine and has become part of the social fabric of the ...

PARIS, Oct 14 (Reuters) - The French government needs guarantees from drugmaker Sanofi (SASY.PA), opens new tab that production of its popular Doliprane painkiller will stay in France to allow the ...